Tag: <span>biopsy</span>

Home / biopsy
Post

Implantable cancer traps could provide earlier diagnosis, help monitor treatment

UNIVERSITY OF MICHIGAN ANN ARBOR–Invasive procedures to biopsy tissue from cancer-tainted organs could be replaced by simply taking samples from a tiny “decoy” implanted just beneath the skin, University of Michigan researchers have demonstrated in mice. These devices have a knack for attracting cancer cells traveling through the body. In fact, they can even pick...

Post

CNIO researchers assess melanoma progression with a new liquid biopsy technique

CENTRO NACIONAL DE INVESTIGACIONES ONCOLÓGICAS (CNIO) When the surgeon surgically removes a melanoma, some patients are said to be ‘cancer-free’ and they do not get additional treatment. However, should the fluid obtained in the drainage implanted after surgery be tested using the liquid biopsy technique rather than be disposed of as medical waste, the test might predict the high or...

Post

Results of early-stage liver cancer detection using liquid biopsy published in PNAS

Highlights: Genetron Health (Beijing) Co. Ltd and National Cancer Center/ Cancer Hospital, Chinese Academy of Medical Sciences published the promising results of their liver cancer early screening study using cell free DNA and protein biomarkers.  This product for screening HCC in at-risk populations, will be further validated and then available for use. This methodology is expected to be applied in early screening of other cancer types. March 12th, 2019, Beijing – Today, Proceedings of...

Post

Clinical trial launches to develop breath test for multiple cancers

Researchers have launched a clinical trial to develop a breath test, analysing molecules that could indicate the presence of cancer at an early stage. This is the first test of its kind to investigate multiple cancer types. A cancer breath test has huge potential to provide a non-invasive look into what’s happening in the body and could help to find cancer early when treatment is more likely to be...

Post

Blood test identifies more treatable cancer mutations than tissue biopsy alone

In one of the largest clinical studies to ever examine the impact of using a blood test to detect treatable mutations in non-small cell lung cancer (NSCLC), researchers from the Abramson Cancer Center of the University of Pennsylvania found that they could identify significantly more mutations through liquid biopsy instead of a solid tissue biopsy alone. The findings also show that patients whose actionable mutations were detected by the blood-based liquid biopsy responded favorably to targeted therapies. Overall,...

Post

New Liquid Biopsy Detects Cancer at Earlier Stages Than Currently Possible

A new liquid biopsy test could detect cancer years before symptoms are apparent, according to research presented today (June 1) at the American Society of Clinical Oncologists (ASCO) meeting in Chicago. The test—a noninvasive blood draw followed by DNA screening—could lead to dramatic changes in cancer treatment, say researchers. “This is potentially the holy grail of cancer...

Post

Noninvasive brain tumor biopsy on the horizon

New technique developed at Washington University in St. Louis uses blood test Taking a biopsy of a brain tumor is a complicated and invasive surgical process, but a team of researchers at Washington University in St. Louis is developing a way that allows them to detect tumor biomarkers through a simple blood test.  IMAGE: A TEAM OF ENGINEERS...

Post

Fiber optic probe beats a biopsy for measuring muscle health

A new fiber optic technique for studying muscle health could remove the need for painful muscle biopsies Diagnosing a muscular disorder, disease or infection often requires a sample of the tissue to be extracted, but these biopsies can be painful and difficult to perform. Researchers at the Rehabilitation Institute of Chicago (RIC) have developed a...

  • 1
  • 2